Microplastics in intravenous infusions: emerging health concerns for medical practitioners

Pinterest LinkedIn Tumblr +

Recent research has uncovered a significant pathway for microplastic (MP) entry into the human body: intravenous (IV) infusions.

A study published in Environment & Health., has revealed that IV infusions administered from polypropylene (PP) plastic bottles can introduce approximately 7,500 PP particles per litre into the bloodstream.

These MPs range in size from 1 to 62 micrometres, with a median size of about 8.5 micrometres. Notably, around 90% of these particles are between 1 and 20 micrometres, and approximately 60% fall within the 1 to 10 micrometre range.

Potential Health Implications

The direct introduction of MPs into the circulatory system raises concerns about their potential deposition in various organs and the subsequent clinical effects. While the full extent of health risks associated with MPs in the bloodstream is still under investigation, this study emphasises the need for healthcare professionals to be aware of this exposure route.

FINDING THE HER2 LOW PATIENT: A PODCAST WITH PROF. FRAN BOYLE AND DR. SANJEEV KUMAR

Recommendations for Healthcare Practice

Given these findings, medical practitioners should consider the following steps to mitigate MP exposure during IV therapy:

  1. Evaluate Infusion Materials: Assess the materials used for IV infusions and consider alternatives to PP plastic bottles when feasible.

  2. Enhance Filtration Techniques: Implement or improve filtration methods to reduce particle contamination in IV solutions.

  3. Stay Informed: Keep abreast of ongoing research regarding MPs in medical settings to make informed decisions about patient care.

This study underscores the importance of scrutinising medical equipment and procedures to minimize unintended health risks. As research progresses, continued vigilance and adaptation of best practices will be crucial in safeguarding patient health against emerging contaminants like microplastics.

 

Paper: Huang, T., et al. MPs Entering Human Circulation through Infusions: A Significant Pathway and Health Concern. Environ. Health 2025, Published February 14, 2025. https://doi.org/10.1021/envhealth.4c00210

Share.

About Author

Rachael Babin is a medical writer, communications expert, digital content producer and trained media host. Rachael co-founded The Oncology Network in 2014. She is Editor-in-Chief of Oncology News Australia, Publisher of The Oncology Newsletter and Host and Creator of The Oncology Podcast. Before creating The Oncology Network, Rachael worked for MOGA, COSA and an international academic publishing house.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.